Astrana Health, Inc.
Close on Oct 19, 2026
- Market cap
- $1.84B
- P/E (TTM)
- 45.0
- Dividend yield
- –
About Astrana Health
Services-Management Consulting Services, SIC 8742
Astrana Health, Inc. is a healthcare management and care delivery company operating primarily through three core segments: Care Delivery, Care Enablement, and Care Partners. The company provides healthcare patient services, management services, and capitated healthcare arrangements. Through its network relationships, management contracts, and affiliated independent physician associations, it coordinates and delivers medical care. Its primary customers and payors comprise patients and members enrolled in Medicare, Medicaid, and commercial health plans, alongside affiliated physicians and medical groups.
The company conducts its operations within the United States, with documented organizational activities and affiliated healthcare entities in California, Texas, and Connecticut. Astrana Health operates through clinical practices, diagnostic and surgical centers, and laboratory facilities. The company is incorporated under the laws of Delaware and maintains its corporate headquarters and principal executive offices in Alhambra, California.
Summary of the business section of Astrana Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Astrana Health, Inc.
- Headquarters
- Alhambra, CA
- Address
- 1668 S. Garfield Avenue, 2nd Floor 91801
- Phone
- (626) 282-0288
- Employees
- 3,000, Dec 31, 2025
- Industry
- Services-Management Consulting Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, Los Angeles, California
Stock & identifiers
- Ticker
- ASTH
- Exchange
- Nasdaq
- Shares outstanding
- 56M, Aug 3, 2026
- Public float
- $1.10B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 1-for-10 reverse, Jul 14, 2015; 1-for-10 reverse, Apr 27, 2015
- SEC CIK
- 1083446
- CUSIP
- 03763A207
- ISIN
- US03763A2078
- LEI
- 5493008O4R82Q4STJ936
- EIN
- 87-0042699
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Kenneth T. Sim | Executive Chairman, Director | 7,692,242 |
| John Vong | SVP - Accounting (PAO) | 22,330 |
| Brandon Sim | CEO and President | 1,890,501 |
| Chandan Basho | COO and CFO | 157,820 |
| Dinesh M. Kumar | Chief Medical Officer | 177,655 |
| Mitchell W. Kitayama | Director | 24,337 |
| David Schmidt | Director | 56,019 |
| Dai, Weili | Director | 18,188 |
| John Chiang | Director | 35,373 |
| Linda Dong | Director | 97,133 |
| Matthew Mazdyasni | Director | 39,288 |
| Thomas S. Lam | Director | 7,732,165 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Brandon KSim | $14.93M | $5.92M | $3.07M | $136 | $148 |
| FY2024 Brandon KSim | $18.24M | $16.94M | $6.67M | $173 | $129 |
| FY2024 Thomas SLam | $2.84M | $2.28M | $6.67M | $173 | $129 |
| FY2023 Brandon KSim | $14.31M | $13.56M | $3.83M | $210 | $126 |
| FY2023 Thomas SLam | $5.22M | $4.31M | $3.83M | $210 | $126 |
| FY2022 Brandon KSim | $15.30M | $997.26K | $1.67M | $162 | $124 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, Astrana, its subsidiaries, and consolidated VIEs had approximately 3,000 employees.”
Corporate history
Events identified from SEC filings